Funding Events for Vertical: Pharmaceuticals
← Back to All Verticals
Loading funding events...
| Company Name | Funding Type | Date Awarded | Vertical |
|---|---|---|---|
| Sollievo Pharmaceuticals | Seed | June 12, 2024 | Pharmaceuticals |
| Sen-Jam Pharmaceutical | Equity | June 13, 2024 | Pharmaceuticals |
| Sollievo Pharmaceuticals | Equity | June 13, 2024 | Pharmaceuticals |
| Formation Bio | Series D | June 26, 2024 | Pharmaceuticals |
| Varda | Seed | January 01, 2024 | Pharmaceuticals |
| Remedy Plan Therapeutics | Series A | May 13, 2025 | Pharmaceuticals |
| Linnea | Acquisition | May 17, 2025 | Pharmaceuticals |
| Ignota Labs | Seed | May 18, 2025 | Pharmaceuticals |
| Paradox Immunotherapeutics | Investment | February 25, 2025 | Pharmaceuticals |
| Perceive Pharma | Series A | May 18, 2025 | Pharmaceuticals |
| Oculis | Public Offering | May 18, 2025 | Pharmaceuticals |
| Azafaros | Series A | May 19, 2025 | Pharmaceuticals |
| Actinium Pharmaceuticals, Inc. | Class Action Lawsuit | May 19, 2025 | Pharmaceuticals |
| Viatris Inc. | N/A | May 19, 2025 | Pharmaceuticals |
| Orbis Medicines | Series A | May 20, 2025 | Pharmaceuticals |
| Cirius Therapeutics | Series A | April 14, 2017 | Pharmaceuticals |
| ANI Pharmaceuticals | Venture Capital | May 20, 2025 | Pharmaceuticals |
| Amplyx Pharmaceuticals | Series B, Series C, Series C Extension | November 11, 2015 | Pharmaceuticals |
| 1200 Pharma | Venture Capital | May 20, 2025 | Pharmaceuticals |
| Crinetics Pharmaceuticals | Series A | November 02, 2015 | Pharmaceuticals |
| Graybug Vision | Series C | August 20, 2019 | Pharmaceuticals |
| GeneriCo | Series A | August 11, 2015 | Pharmaceuticals |
| GSK | Venture Capital | May 21, 2025 | Pharmaceuticals |
| Glo Pharma | Venture Capital | May 21, 2025 | Pharmaceuticals |
| Adynxx | Series B | January 11, 2017 | Pharmaceuticals |
| Belmar Pharma Solutions | Venture Capital | May 21, 2025 | Pharmaceuticals |
| Centrexion Therapeutics | Series D | January 02, 2018 | Pharmaceuticals |
| Catalent | Venture Capital | May 21, 2025 | Pharmaceuticals |
| CaloSyn Pharma | Venture Capital | May 21, 2025 | Pharmaceuticals |
| Arixa Pharmaceuticals | Seed | May 01, 2018 | Pharmaceuticals |
| Corsair Pharma | Series B | September 20, 2023 | Pharmaceuticals |
| Belmar Pharmacy | Venture Capital | May 22, 2025 | Pharmaceuticals |
| Folium Biosciences | Venture | January 15, 2019 | Pharmaceuticals |
| First Aid Shot Therapy | Series C | November 18, 2015 | Pharmaceuticals |
| FemmePharma | Venture Capital | May 22, 2025 | Pharmaceuticals |
| Deciphera Pharmaceuticals | Series B and C | September 21, 2015 | Pharmaceuticals |
| Edgemont Pharmaceuticals | Venture Capital | May 22, 2025 | Pharmaceuticals |
| Exo Therapeutics | Series A | December 16, 2020 | Pharmaceuticals |
| Formation Bio | Series D | June 26, 2024 | Pharmaceuticals |
| HLS Therapeutics | Venture Capital | May 23, 2025 | Pharmaceuticals |
| Imbria Pharmaceuticals | Series B | April 10, 2025 | Pharmaceuticals |
| Ista Pharmaceuticals | Venture Capital | May 23, 2025 | Pharmaceuticals |
| Kiniksa Pharmaceuticals | Venture Capital | May 24, 2025 | Pharmaceuticals |
| Livionex ( LIVFRESH Dental) | Series A | May 13, 2019 | Pharmaceuticals |
| Leading Pharma | Growth | January 08, 2018 | Pharmaceuticals |
| Mobilion Systems | Series C | July 15, 2021 | Pharmaceuticals |
| Karuna Therapeutics | Series A | August 04, 2018 | Pharmaceuticals |
| Macrolide Pharmaceuticals | Series A | March 04, 2015 | Pharmaceuticals |
| Mark Cuban Cost Plus Drug Company | Venture Capital | May 24, 2025 | Pharmaceuticals |
| Nacuity Pharmaceuticals | Series B | June 15, 2022 | Pharmaceuticals |
| Lung Therapeutics | Series B | June 06, 2017 | Pharmaceuticals |
| Melt Pharmaceuticals | Series B | April 02, 2024 | Pharmaceuticals |
| Lyndra Therapeutics | Series E | December 21, 2023 | Pharmaceuticals |
| NephroDI Therapeutics | Venture | June 20, 2024 | Pharmaceuticals |
| Tremeau Pharmaceuticals | Venture Capital | May 25, 2025 | Pharmaceuticals |
| RENOVION | Series A | June 18, 2020 | Pharmaceuticals |
| Sebela Pharmaceuticals | Venture Capital | May 25, 2025 | Pharmaceuticals |
| TrialSpark | Series C | September 30, 2021 | Pharmaceuticals |
| Tioga Pharmaceuticals | Venture Capital | May 25, 2025 | Pharmaceuticals |
| QR Pharma | Series A | October 28, 2016 | Pharmaceuticals |
| Spyglass Pharma | Series C | July 10, 2023 | Pharmaceuticals |
| Satsuma Pharmaceuticals | Series A | January 09, 2017 | Pharmaceuticals |
| Qnovia | Series B | December 10, 2024 | Pharmaceuticals |
| Reneo Pharmaceuticals | Series A | May 20, 2019 | Pharmaceuticals |
| RXQ Compounding | Equity | August 24, 2018 | Pharmaceuticals |
| RECRO Pharma | Venture Capital | May 26, 2025 | Pharmaceuticals |
| Royalty Pharma | Venture Capital | May 26, 2025 | Pharmaceuticals |
| Slayback Pharma | Series B | January 06, 2020 | Pharmaceuticals |
| SciTech Development | HR | June 07, 2023 | Pharmaceuticals |
| TBT Pharma | Venture Capital | May 26, 2025 | Pharmaceuticals |
| Ratio Therapeutics | Series B | January 17, 2024 | Pharmaceuticals |
| TARIS Biomedical | Venture | October 27, 2015 | Pharmaceuticals |
| Sayvaa Pharma | Venture Capital | May 26, 2025 | Pharmaceuticals |
| Sydnexis | Series B | August 10, 2021 | Pharmaceuticals |
| QuVa Pharma | Debt Financing | May 06, 2021 | Pharmaceuticals |
| Syros Pharmaceuticals | Venture Capital | May 27, 2025 | Pharmaceuticals |
| ShouTi | Series B | October 20, 2021 | Pharmaceuticals |
| Village Fertility Pharmacy | Venture Capital | May 27, 2025 | Pharmaceuticals |
| Vtesse, Inc. | Series A | January 07, 2015 | Pharmaceuticals |
| Vapogenix | Series C | December 09, 2016 | Pharmaceuticals |
| Venatorx Pharmaceuticals | Series B | July 26, 2017 | Pharmaceuticals |
| X-37 | Series A | November 15, 2019 | Pharmaceuticals |
| Y Tetherex Pharmaceuticals | Venture Capital | May 27, 2025 | Pharmaceuticals |
| Wilmington Pharmaceuticals | Venture Capital | May 27, 2025 | Pharmaceuticals |
| UroGen Pharma Ltd. | Class Action Lawsuit | May 30, 2025 | Pharmaceuticals |
| Checkpoint Therapeutics | Acquisition | May 30, 2025 | Pharmaceuticals |
| Qnovia | Series B | May 30, 2025 | Pharmaceuticals |
| Aqemia | Series A | May 31, 2025 | Pharmaceuticals |
| HER3-DXd | Clinical Trial | May 31, 2025 | Pharmaceuticals |
| BIAL | N/A | June 02, 2025 | Pharmaceuticals |
| Blueprint Medicines | Acquisition | June 02, 2025 | Pharmaceuticals |
| Viatris Inc. | Securities Fraud Lawsuit Opportunity | June 02, 2025 | Pharmaceuticals |
| Antheia | Series C | June 04, 2025 | Pharmaceuticals |